News | December 20, 2023
Clariant Healthcare debuts in CPhI India
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Subscribe To Our Newsletter & Stay Updated
